James L. Tyree, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 4,587 shares at $56.08 ($255K) on 2008-02-19, disclosed to the SEC on 2008-02-20.
Scheduled sale ($255k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.55 | 3,019 | $168K | 65.7% |
| 2 | $55.55 | 684 | $38K | 14.9% |
| 3 | $56.08 | 284 | $16K | 6.2% |
| 4 | $56.08 | 600 | $34K | 13.2% |
| Total | $55.65 avg | 4,587 | $255K | 100% |
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |